Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

NCT03849560

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after academician I.P. Pavlova "of the Ministry of Health of the Russian Federation. Saint Petersburg, Leningradskaya Oblast', Russia
  • Federal State Budgetary Institution "Children's Scientific and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency" Saint Petersburg, Leningradskaya Oblast', Russia
  • Smorodintsev Research Institute of Influenza Saint Petersburg, Leningradskaya Oblast', Russia
View Trial Details
Completed

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

NCT02860039

Conditions
Hematopoietic Cell Transplantation Recipient, Infections, Influenza, +8 more
Locations
  • UCSF Children's Hospital San Francisco, California, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Completed

Respiratory Virus Hospitalization Study (FLU 003 Plus)

NCT01056185

Conditions
Coronaviridae Infections, Coronavirus Infections, Infections, +11 more
Locations
  • UCSD Antiviral Research Center San Diego, California, United States
  • George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Washington DC VA Medical Center Washington D.C., District of Columbia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
View all 63 locations
View Trial Details
Completed

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

NCT04782323

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • 03607 - PCRN_Paratus Clinical Research Bruce, Australian Capital Territory, Australia
  • 03605 - PCRN_Paratus Clinical Research (Central Coast) Blacktown, New South Wales, Australia
  • 3610- Emeritis Research Botany, New South Wales, Australia
  • 3609 - Northern Beaches Clinical Research [NSW] Brookvale, New South Wales, Australia
View all 30 locations
View Trial Details

Related conditions